Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-957-0 | CAS number: 598-94-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March - October 2014
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: The Guidelines for the Testing of Chemicals (Ministry of Environmental Protection of the People’s Republic of China, 2004)
- Qualifier:
- according to guideline
- Guideline:
- other: The Guidelines for the hazard Evaluation of New Chemical Substances (Ministry of Environmental Protection of the People’s Republic of China, 2004)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 1,1-dimethylurea
- EC Number:
- 209-957-0
- EC Name:
- 1,1-dimethylurea
- Cas Number:
- 598-94-7
- Molecular formula:
- C3H8N2O
- IUPAC Name:
- 1,1-dimethylurea
- Reference substance name:
- Urea
- EC Number:
- 200-315-5
- EC Name:
- Urea
- Cas Number:
- 57-13-6
- Molecular formula:
- CH4N2O
- IUPAC Name:
- urea
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- dihydrogen oxide
- Test material form:
- solid: crystalline
Constituent 1
impurity 1
impurity 2
- Specific details on test material used for the study:
- - Analytical purity: 99.9 %
- Lot/batch No.: 301601
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- mammalian liver post-mitrochondrial fraction (S9)
- Test concentrations with justification for top dose:
- Three adequately spaced concentrations of the test substance were used (50, 500, 5000 µg/mL). The highest concentration gave rise to a significant toxic effect but still allowed adequate cell replication to occur. Cells were exposed to the test substance in the presence and absence of S9-mix. The cultures were treated with the test substance preparation in the presence of S9 for 6 hours and in the absence for 6 and 24 hours. At the end of the exposure period, cells were washed free of test substance and cultured for two rounds of replication.
- Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- see "any other information on materials and methods incl. tables"
- Evaluation criteria:
- In the following two cases the results of the experimental system would be determined as positive:
(1) The number of chromosome structural aberrations caused by the test substance increases statistically significantly and the increase is concentration-dependent.
(2) The test substance causes a statistically significant increase of structural aberrations and the increase is shown to be repeatable.
Negative results are only stated when cell toxicity was obvious and chromosomal aberrations significantly increased. In this case the evaluation must consider the biological and statistical significance of the finding. - Statistics:
- Statistical analysis of the percent aberrant cells was performed using the Chi-square test to evaluate if there were any significant differences between the dose and control groups.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Significant toxic effects in highest concentration, but adequate cell replication still occured
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- see "any other information on results incl. tables"
Any other information on results incl. tables
Preliminary Toxicity Assay
Dose levels for the chromosome aberration assay were selected following the results of a preliminary toxicity test and were based upon a reduction in the mitotic index, relative to the solvent control. Based on Trypan blue counting method, the IC50(IC50: concentration at which the cell inhibition ratio reached 50%) was greater than 5000μg/ml. Since the cytotoxicity of the test substance is relatively low, 5000 ug/ml was adopted as the highest concentration in the definite test. The other two concentration levels were selected to be 500 ug/ml and 50 ug/ml accordingly.
Chromosome Aberration Assay
In the absence ofS9- mixandtreatment for 6 h, the cell aberration rate of blank control, solvent control, 50, 500, 5000 ug/ml dose group and the positive control was 0.5 %,0.5 %,1 %,2 %,2.5 %,31.5 %, respectively (see table 2). The mitosis inhibition rates of the three test substance concentrations were6.49%,19.12%,44.09%, respectively (see table 1).
In the presence ofS9 and treatment for 6 h, the cell aberration rate ofblank control, solvent control,50, 500, 5000 ug/ml dose group and the positive control cell aberration rate was 1 %,0.5 %, 0.5 %,1 %, 1.5 %,27.5 % respectively (see table 2). The mitotic inhibition rates of the test substance concentrations were0.05 %,20.31 %,42.00 %, respectively (see table 1).
In the absence of S9 and treatment for 24 h, the cell aberration rate of blank control, solvent control, 50, 500, 5000 ug/ml dose group and the positive control cell aberration rate was1 %,1 %,1.5 %,2 %,2.5 %,36 %, respectively (see table 3). The mitosis inhibition rates for the three test substance concentrations were1.17 %,34.66 %,55.24 % (see table 1).
Statistical analysis of the percent aberrant cells was performed using the Chi-square test to evaluate if there are any significant differences between the dose and control groups. When comparing the positive control group with the solvent control group, the differences were statistically significant (P <0.01). Treated groups compared with the solvent control group, showed a difference that was not statistically significant (P>0.05).
Table 1: Results of the mitotic indices.
Treatment (ug/ml) |
-S9(6h) Mitotic index
|
- S9(6h) inhibition rate |
+ S9(6h) Mitotic index
|
+ S9(6h) inhibition rate |
- S9(24h) Mitotic index
|
- S9(24h) inhibition rate |
Solvent control |
6.15% |
- |
6.14% |
- |
6.00% |
- |
50 |
5.40% |
6.49% |
6.09% |
0.05% |
5.93% |
1.17% |
500 |
4.67% |
19.12% |
4.92% |
20.31% |
4.00% |
34.66% |
5000 |
3.23% |
44.09% |
3.67% |
42.00% |
2.81% |
55.24% |
Table 2: Cytogenetic analysis of CHL cells treated with 1,1 -Dimethylurea (6 hour treatment)
Treatment |
Concentration (μg/ml) |
S9 |
Cells Scored |
Total number of aberrations
Gaps Br Ex Poly |
Number of aberration cells |
Aberration rate(%) |
Results |
|||
Blank control |
0 |
- |
200 |
2 |
1 |
0 |
1 |
1 |
0.5 % |
- |
Solvent control |
0.1% DMSO |
- |
|
3 |
1 |
0 |
2 |
0 |
0.5 % |
- |
|
50 |
- |
200 |
2 |
2 |
0 |
1 |
2 |
1 % |
- |
500 |
- |
200 |
4 |
3 |
1 |
1 |
4 |
2 % |
- |
|
5000 |
- |
200 |
2 |
4 |
1 |
2 |
5 |
2.5 % |
- |
|
MMC |
0.1 |
- |
200 |
12 |
33 |
38 |
5 |
63 |
31.5 %** |
+ |
Blank control |
0 |
+ |
200 |
2 |
1 |
1 |
1 |
2 |
1 % |
- |
Solvent control |
0.1% DMSO |
+ |
|
4 |
0 |
1 |
1 |
1 |
0.5 % |
- |
|
50 |
+ |
200 |
2 |
1 |
0 |
1 |
1 |
0.5 % |
- |
500 |
+ |
200 |
2 |
2 |
0 |
1 |
2 |
1 % |
- |
|
5000 |
+ |
200 |
1 |
3 |
0 |
2 |
3 |
1.5 % |
- |
|
CP |
10 |
+ |
200 |
15 |
32 |
22 |
3 |
55 |
27.5 %** |
+ |
Note: **, compared with solvent control culture, P < 0.01; Br refers to chromatid break and chromosome break; Ex refers to exchange figure; MMC: Mitomycin; CP: Cyclophoshamide; Poly refers to polyploidy; +: positive; -: negative.
Table 3: Cytogenetic analysis of CHL cells treated with 1,1-dimethylurea (24hour treatment)
Treatment |
Concentration (μg/ml) |
S9 |
Cells Scored |
Total number of aberrations
Gaps Br Ex poly |
Number of aberration cells |
Aberration rate(%) |
Results |
|||
Blank control |
0 |
- |
200 |
2 |
1 |
1 |
1 |
2 |
1 % |
- |
Solvent control |
0.1% DMSO |
- |
200 |
3 |
1 |
1 |
2 |
2 |
1 % |
- |
|
50 |
- |
200 |
1 |
2 |
1 |
1 |
3 |
1.5 % |
- |
500 |
- |
200 |
2 |
4 |
0 |
5 |
4 |
2 % |
- |
|
5000 |
- |
200 |
3 |
5 |
0 |
5 |
5 |
2.5 % |
- |
|
MMC |
0.1 |
- |
200 |
10 |
39 |
42 |
3 |
72 |
36 %** |
+ |
Note: **, compared with solvent control culture, P < 0.01;Br refers to chromatid break and chromosome break;Ex refers to exchange figure; MMC: Mitomycin; CP: Cyclophoshamide;Poly refers to polyploidy; +: positive; -: negative.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the test 1,1-Dimethylurea was concluded to be negative for the induction of structural chromosome aberrations with and without metabolic activation using Chninese Hamster Lung cells.
- Executive summary:
The substance 1,1 -Dimethylurea was tested in an in vitro Mammalian Chromosome Aberration Test using Chinese hamster lung (CHL) cells cultures. Treatments were performed both in the absence and presence of a S9 activation system. The chromosome aberration assay was used to evaluate the clastogenic potential of the test substance.
The cells were treated for 6 and 24 hours in the non-activated test system and for 6 hours in the S9-activated test system. Mammalian chromosome aberration was analyzed at three dose levels (50, 500 and 5000mg/ml), continuously for 6 hours and 24 hours. Blank control,solvent control and positive control cultures were included in the test system.
Chromosome aberrationrate of CHL in the absence of S9 and treated for 6 h was 1 %, 2 % and 2.5 % in 50, 500 and 5000 μg/ml treated groups, respectively. Chromosome aberration rate of CHL in the presence of S9 and treated for 6 h was 0.5 %,1 % and 1.5 % in 50, 500 and 5000 μg/ml treated groups,,respectively. Chromosome aberrationrate of CHL in the absence of S9 and treated for 24 h was 1.5 %, 2 % and 2.5 % in 50, 500 and 5000 μg/mL treated groups, respectively.The percentage of cells with structural aberrations in the test substance-treated groups was not increased relative to the solvent control at any dose level (p > 0.05, Chi-square test).
Based on the findings of this study,1,1 -Dimethylurea was concluded to be negative for the induction of structural chromosome aberrations in both non-activated and S9-activated test systems in the in vitro mammalian chromosome aberration test using CHL.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.